MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04690nam a2200253Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
NULRC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250520100625.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250520s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780071813501 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
NULRC |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM 301.13 .T74 2013 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Trevor, Anthony J. |
| Relator term |
author |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Katzung and Trevor's pharmacology : |
| Remainder of title |
examination and board review / |
| Statement of responsibility, etc. |
Anthony J. Trevor [and three others] |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Tenth edition. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
New York : |
| Name of publisher, distributor, etc. |
McGraw Hill Education, |
| Date of publication, distribution, etc. |
c2013 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
vi, 646 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
28 cm. |
| 365 ## - TRADE PRICE |
|---|
| Price amount |
PHP1598 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Part I. Basic principles -- Introduction -- Pharmacodynamics -- Pharmacokinetics -- Drug metabolism -- Drug evaluation & regulation -- Part II. Autonomic drugs -- Introduction to autonomic pharmacology -- Cholinoceptor-activating & cholinesterase-inhibiting drugs -- Cholinoceptor blockers & cholinesterase regenerators -- Sympathomimetics -- Adrenoceptor blockers -- Part III. Cardiovascular drugs -- Drugs used in hypertension -- Drugs used in the treatment of angina pectoris -- Drugs used in heart failure -- Antiarrhythmic drugs -- Diuretic agents -- Part IV. Durgs with important actions on smooth muscle -- Histamine, serotonin, & the ergot alkaloids -- Vasoactive peptides -- Prostaglandins & other eicosanoids -- Nitric oxide, donors, & inhibitors -- Drugs used in asthma & chronic obstructive pulmonary disease -- Part V. Drugs that act in the central nervous system -- Introduction to CNS pharmacology -- Sedative-hypnotic drugs -- Alcohols -- Antiseizure drugs -- General anesthetics -- Local anesthetics -- Skeletal muscle relaxants -- Drugs used in Parkinsonism & other movement disorders -- Antipsychotic agents & lithium -- Antidepressants -- Opioid analgesics & antagonists -- Drugs of abuse -- Part VI. Drugs with important actions on blood, inflammation, and gout -- Agents used in anemias & hematopoietic growth factors -- Drugs used in coagulation disorders -- Drugs used in the treatment of hyperlipidemias -- NSAIDs, acetaminophen, & drugs used in rheumatoid arthritis & gout -- Part VII. Endocrine drugs -- Hypothalamic & pituitary hormones -- Thyroid & antithyroid drugs -- Corticosteroids & antagonists -- Gonadal hormones & inhibitors -- Pancreatic hormones, antidiabetic agents, & glucagon -- Drugs that affect bone mineral homeostasis -- Part VIII. Chemotherapeutic drugs -- Beta-lactam antibiotics & other cell wall synthesis inhibitors -- Chloramphenicol, tetracyclines, macrolides, clindamycin, streptogramins, & linezolid -- Aminoglycosides -- Sulfonamides, trimethoprim, & fluoroquinolones -- Antimycobacterial drugs -- Antifungal agents -- Antiviral chemotherapy & prophylaxis -- Miscellaneous antimicrobial agents & urinary antiseptics -- Clinical use of antimicrobials -- Antiprotozoal drugs -- Antihelminthic drugs -- Cancer chemotherapy -- Immunopharmacology -- Part IX. -- Toxicology -- Environmental and occupational toxicology -- Heavy metals -- Management of the poisoned patient -- Part X. Special topics -- Drugs used in gastrointestinal disorders -- Dietary supplements & herbal medications -- Drug interactions -- Appendix I. Key words for key drugs -- Appendix II. Examination 1 -- Appendix III. Examination 2 -- Appendix IV. Strategies forimproving test performance. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Twelfth Edition, this review delivers a clear, concise review of fundamental concepts backed by more than 1,000 review questions and answers. The chapter-based approach facilitates use with course notes or larger texts. Outstanding learning aids include: Short discussion of the major concepts that underlie basic principles or specific drug groups. Explanatory figures and tables. Review questions followed by answers and explanations. Drug trees in drug-oriented chapters that visually organize drug groups. A list of high-yield terms and definitions you need to know. Skill Keeper Questions that prompt you to review previous material to understand links between related topics. A checklist of tasks you should be able to perform upon completion of a chapter. Summary tables that list the important drugs and include key information about their mechanisms of action, effects, clinical uses, pharmacokinetics, drug interactions, and toxicities. Two comprehensive 100-question examinations followed by the correct answers and rationales. Valuable test-taking strategies for improving your test performance. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
PHARMCOLOGY -- EXAMINATIONS, QUESTIONS, ETC |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Katzung, Bertram G.;Kruidering-Hall, Marieke;Masters, Susan B. |
| Relator term |
co-author;co-author;co-author |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books |
